ArticleTobacco control2025
Social determinants of support for tobacco control policies to end the use of commercial cigarettes: findings from the 2022 International Tobacco Control Four Country Smoking and Vaping Survey.
Article in Tobacco control, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundSome countries are exploring policies that might help lower cigarette smoking prevalence to below 5% by 2030. This study assesses support for three policies among adults who smoke: (1) ending smoked tobacco sales within 10 years; (2) limiting cigarette nicotine content to make them less addictive; and (3) restricting smoked tobacco sales for life to anyone currently under 18 (Smoke-Free Generation, SFG).
methodsData were from the 2022 International Tobacco Control Four Country Smoking and Vaping Survey, including 2723 adults who smoked at least monthly in Australia, Canada, England and the USA. We estimated the weighted prevalence of support and used logistic regression to assess whether support (vs no support) differed by sociodemographic variables (country, gender, age, race/ethnicity, education, income).
resultsSupport was 27.1% for ending smoked tobacco sales within 10 years, 53.5% for limiting the nicotine content of cigarettes and 51.7% for an SFG law. US adults had consistently lower odds of support compared with those in Canada and England (all policies: p<0.01). Women and white individuals had lower odds of supporting an end to smoked tobacco sales (adjusted OR (aOR): 0.63, p=0.02; 0.68, p=0.03) and an SFG law (aOR: 0.72, p=0.04; 0.66, p=0.01). Women (aOR: 1.41, p<0.01) were more supportive of nicotine reduction. Individuals with moderate (aOR vs high: 1.34, p=0.03) and low (aOR: 1.41, p=0.03) education, and those with financial difficulties (aOR: 1.36, p=0.04) showed higher support for an SFG law. No differences in support were observed by age in the pooled data.
conclusionsSupport for policies to reduce the use of commercial cigarettes was moderate-to-high among adults who smoke, although it varied significantly by country, gender and income. Tailored communication strategies could help increase support and promote policy adoption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.